With the COVID-19 pandemic, the evolutionary
fate of SARS-CoV-2
becomes a matter of utmost concern. Mutation D614G in the spike (S)
protein has become dominant, and recent evidence suggests it yields
a more stable phenotype with higher transmission efficacy. We carry
out a structural analysis that provides mechanistic clues on the enhanced
infectivity. The D614G substitution creates a sticky packing defect
in subunit S1, promoting its association with subunit S2 as a means
to stabilize the structure of S1 within the S1/S2 complex. The results
raise the therapeutic possibility of immunologically targeting the
epitope involved in stabilizing the G614 phenotype as a means of reducing
the infection efficacy of SARS-CoV-2. This therapeutic modality would
not
a-priori
interfere directly with current efforts
toward the immunological targeting of the RBD epitope; hence, it could
be exploited as a complementary treatment.